Bellevue Funds (Lux) Bellevue Obesity Solutions I2 Fonds
164,01
EUR
+0,47
EUR
+0,29
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Eli Lilly and Co | US5324571083 | 8,49% |
| UnitedHealth Group Inc | US91324P1021 | 8,37% |
| Novo Nordisk AS Class B | DK0062498333 | 5,59% |
| Johnson & Johnson | US4781601046 | 4,93% |
| Intuitive Surgical Inc | US46120E6023 | 3,55% |
| Thermo Fisher Scientific Inc | US8835561023 | 3,27% |
| Abbott Laboratories | US0028241000 | 3,11% |
| AstraZeneca PLC ADR | US0463531089 | 2,99% |
| Novartis AG Registered Shares | CH0012005267 | 2,77% |
| Roche Holding AG | CH0012032048 | 2,72% |
| Sonstige | 54,22% |